(Total Views: 58)
Posted On: 09/29/2020 11:50:47 AM
Post# of 85602

$KLDO News Article - Kaleido Biosciences Announces First Patient Dosed in Clinical Study of Microbiome Metabolic Therapy KB295 in Patients with Mild-to-Moderate Ulcerative Colitis https://marketwirenews.com/news-releases/kale...83638.html


My Twitter: WhyteStocks